Limdi, N. A., Cavallari, L. H., Lee, C. R., Hillegass, W. B., Holmes, A. M., Skaar, T. C., . . . Peterson, J. F. (2020). Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data. Pharmacogenomics J.
Chicago Style citaatLimdi, Nita A., et al. "Cost-effectiveness of CYP2C19-guided Antiplatelet Therapy in Patients With Acute Coronary Syndrome and Percutaneous Coronary Intervention Informed By Real-world Data." Pharmacogenomics J 2020.
MLA citatieLimdi, Nita A., et al. "Cost-effectiveness of CYP2C19-guided Antiplatelet Therapy in Patients With Acute Coronary Syndrome and Percutaneous Coronary Intervention Informed By Real-world Data." Pharmacogenomics J 2020.